Loading...
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133(+) Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy
According to the European Medicine Agency (EMA) regulatory frameworks, Advanced Therapy Medicinal Products (ATMP) represent a new category of drugs in which the active ingredient consists of cells, genes, or tissues. ATMP-CD133 has been widely investigated in controlled clinical trials for cardiovas...
Na minha lista:
| Udgivet i: | Biomed Res Int |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi Publishing Corporation
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4606188/ https://ncbi.nlm.nih.gov/pubmed/26495296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/473159 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|